Gene and Cell Therapies for Blood Disorders

Gene and cell therapies are cutting-edge medical procedures that alter the patient's genetic makeup or cells in an effort to treat or improve blood diseases.
 
Gene therapy includes adding new genes or altering existing genes to treat genetic mutations that result in blood problems. To do this, the new genetic material might be introduced into the patient's cells via viruses or other vectors. Inherited blood diseases including sickle cell disease and beta-thalassemia have showed potential for treatment with gene therapy.
 
In cell therapy, damaged cells in the body are replaced or repaired using healthy cells, such as immune or stem cells. For instance, cell treatment known as hematopoietic stem cell transplantation (HSCT) has been utilised for many years to treat certain blood illnesses. New cell treatments have been developed in recent years, such as chimeric antigen receptor (CAR) T-cell therapy, which alters the immune system of a patient to target cancer cells.
 

 

  • Gene Editing for Hemoglobinopathies
  • CAR T-Cell Therapy for Hematologic Malignancies
  • Gene Therapy for Inherited Bleeding Disorders
  • Cell-Based Therapies for Thrombotic Disorders

Related Conference of Gene and Cell Therapies for Blood Disorders

February 24-25, 2025

4th European Congress on Hematology

Madrid, Spain
May 05-06, 2025

21st Global Summit on Hematology and Blood Disorders

Rome, Italy
July 07-08, 2025

23rd World Hematology Congress

Zurich, Switzerland

Gene and Cell Therapies for Blood Disorders Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in